---
category: news
title: "FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson's Disease"
excerpt: "These cells are then evaluated for potential activity using robust quality control assays, including Aspen's proprietary artificial intelligence-based genomics tests, before being implanted. About ANPD001 ANPD001 is an investigational cell therapy ..."
publishedDateTime: 2023-10-19T13:12:00Z
originalUrl: "https://www.lelezard.com/en/news-21111418.html"
webUrl: "https://www.lelezard.com/en/news-21111418.html"
type: article

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "y7OpIx4cr3DPAjGuhaEwauhg832VVDxA3oryxYkCWQXvp2NitYOprX5wciaQLkUFmw47SRX3Lm4RfyKgzjmYCksQG2Vn+DJV23pFm7MNtr1FqR39PI9Gzc8xq0PHC8bhztgS2aP1/7HRT0RIJG0h34M0IXLaTxZ+SBuogxJjTGhOH5YKYh/BE/qiyROCp1hN856X7SylxoQIEhSOGMx6COu1ZWK00DS0pWPp1ivlXRwSmj5O5j/VPr/lBLFqgm3jQqB5i2VtbR1Q2Wd5pYd7oZ0Nokqplsz+BWUzSyzwlKfgYXnsmS927HzQWCnbUFKMkARcLI+UUDaL4aXe0x5aP/rloveKctgkblrt5jsC6Rc=;vzjgZrH06ToWTI3aYhKWFg=="
---

